These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33615852)

  • 1. A simple algorithm for a clinical step-by-step approach in the management of hypertrophic cardiomyopathy.
    Efthimiadis G; Zegkos T; Parcharidou D; Ntelios D; Panagiotidis T; Gossios T; Karvounis H
    Future Cardiol; 2021 Nov; 17(8):1395-1405. PubMed ID: 33615852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Narrative Review of the Pathophysiology and Treatment of Hypertrophic Cardiomyopathy.
    Gelpi Acevedo LM; Salinas AL; Polanco JS; Nizami H; Marsh D; Patel M; Parikh K; Jain R; Jain R
    South Med J; 2022 Dec; 115(12):926-929. PubMed ID: 36455903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy.
    Subasic K
    Nurs Clin North Am; 2013 Dec; 48(4):571-84. PubMed ID: 24295188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy.
    Gartzonikas IK; Naka KK; Anastasakis A
    Hellenic J Cardiol; 2023; 70():65-74. PubMed ID: 36403865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):212-216. PubMed ID: 31004609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.
    Fananapazir L; McAreavey D
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):478-501. PubMed ID: 9058851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement.
    Limongelli G; Masarone D; Frisso G; Iacomino M; Ferrara I; Rea A; Gravino R; Bossone E; Salvatore F; Calabro R; Elliott P; Pacileo G
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):249-254. PubMed ID: 26808413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique Aspects of Hypertrophic Cardiomyopathy in Children.
    Townsend M; Jeewa A; Khoury M; Cunningham C; George K; Conway J
    Can J Cardiol; 2024 May; 40(5):907-920. PubMed ID: 38244986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy: infants, children, and adolescents.
    Maskatia SA
    Congenit Heart Dis; 2012; 7(1):84-92. PubMed ID: 22222117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy.
    Ni E; Wang T; Zhang X; Xie H
    ESC Heart Fail; 2023 Aug; 10(4):2711-2717. PubMed ID: 37271167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic screening of patients with hypertrophic cardiomyopathy--a new diagnostic strategy for risk stratification?
    Hudecova K; Simkova I; Gardlik R; Bernadic M
    Bratisl Lek Listy; 2009; 110(2):85-92. PubMed ID: 19408839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy.
    Coppini R; Santini L; Olivotto I; Ackerman MJ; Cerbai E
    Cardiovasc Res; 2020 Jul; 116(9):1585-1599. PubMed ID: 32365196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Treatment Strategies for Hypertrophic Cardiomyopathy.
    Hutt E; Desai MY
    Am J Cardiol; 2024 Feb; 212S():S33-S41. PubMed ID: 38368034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
    Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.